je.st
news
Home
› Librede Receives Phase I SBIR To Develop Yeast-Based Cannabinoid Production And Drug Discovery Platform
Librede Receives Phase I SBIR To Develop Yeast-Based Cannabinoid Production And Drug Discovery Platform
2016-03-30 06:19:04| drugdiscoveryonline Home Page
Librede, a biotechnology company specializing in yeast-based cannabinoid production, announced that it has received a Small Business Innovative Research (SBIR) grant from the National Center for Complementary & Integrative Health (NCCIH) of the National Institutes of Health (NIH)
Tags: production
develop
drug
phase
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|